secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001654954-23-013399
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech regains Nasdaq minimum bid price compliance; delisting risk removed
--------------------------------------------------------------------------------

- Received Nasdaq letter confirming compliance with minimum bid price of $1.00/share after 10 consecutive business days.
- Previously received deficiency notice on June 22, 2023 with compliance deadline of December 19, 2023.
- Common shares (EDSA) now meet Nasdaq Capital Market listing requirement; matter closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000165495423013399/0001654954-23-013399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000165495423013399/edsa_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-013399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer